HCPCS Code Q9989

Ustekinumab, for intravenous injection, 1 mg
Code effective Jan 01, 2018

HCPCS Section
Miscellaneous Services (Temporary Codes)

Q9989 is a valid 2026 HCPCS code meaning Ustekinumab, for intravenous injection, 1 mg or (Ustekinumab, iv inject,1 mg) for short. HCPCS Q9989 has been effective since 01/01/2018 and applies to Medical care.

HCPCS Code Details - Q9989

HCPCS Level II Code
Section Q - Miscellaneous Services (Temporary Codes)
HCPCS Code Q9989
Description

Long description:
Ustekinumab, for intravenous injection, 1 mg

Short description:
Ustekinumab, iv inject,1 mg

HCPCS Pricing indicator 51 - Drugs
Multiple pricing indicator A - Not applicable as HCPCS priced under one methodology
Coverage code C - Carrier judgment
BETOS2 code O1E - Other drugs
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2018
Date added Added Jul 01, 2017
Termination date Dec 31, 2017

See also

  • HCPCS Q9988 · Platelets, pheresis, pathogen-reduced, each unit

  • HCPCS C9487 · Ustekinumab, for intravenous injection, 1 mg

  • HCPCS J3358 · Ustekinumab, for intravenous injection, 1 mg

  • HCPCS Q9991 · Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.